ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)2012

TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis.

Liliana Guedez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.